Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) EPS (Basic) (2019 - 2025)

Volitionrx filings provide 9 years of EPS (Basic) readings, the most recent being $0.01 for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 103.2% to $0.01 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.15, a 69.6% increase, with the full-year FY2025 number at -$0.22, up 29.03% from a year prior.
  • EPS (Basic) hit $0.01 in Q4 2025 for Volitionrx, up from -$0.0 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.17 in Q4 2022 to a low of -$10.08 in Q4 2023.
  • Median EPS (Basic) over the past 5 years was -$0.1 (2024), compared with a mean of -$0.57.
  • Biggest five-year swings in EPS (Basic): surged 216.38% in 2022 and later plummeted 9442.49% in 2023.
  • Volitionrx's EPS (Basic) stood at -$0.15 in 2021, then surged by 216.38% to $0.17 in 2022, then crashed by 5877.09% to -$10.08 in 2023, then surged by 97.78% to -$0.22 in 2024, then surged by 103.2% to $0.01 in 2025.
  • The last three reported values for EPS (Basic) were $0.01 (Q4 2025), -$0.0 (Q3 2025), and $0.0 (Q2 2025) per Business Quant data.